Background: Early inflammatory processes may play an important role in the development of early brain injury (EBI) after subarachnoid hemorrhage (SAH). Experimental studies suggest that anti-inflammatory and membranestabilizing drugs might have beneficial effects, although the underlying mechanisms are not fully understood. The aim of this study was to investigate the effect of early treatment with methylprednisolone and minocycline on cerebral perfusion and EBI after experimental SAH. Methods: Male Sprague-Dawley rats were subjected to SAH using the endovascular filament model. 30 minutes after SAH, they were randomly assigned to receive an intravenous injection of methylprednisolone (16mg/kg body weight, n=10), minocycline (45mg/kg body weight, n=10) or saline (n=11). Mean arterial blood pressure (MABP), intracranial pressure (ICP) and local cerebral blood flow (LCBF) over both hemispheres were recorded continuously for three hours following SAH. Neurological assessment was performed after 24 hours. Hippocampal damage was analyzed by immunohistochemical staining (caspase 3). Results: Treatment with methylprednisolone or minocycline did not result in a significant improvement of MABP, ICP or LCBF. Animals of both treatment groups showed a non-significant trend to better neurological recovery compared to animals of the control group. Mortality was reduced and hippocampal damage significantly attenuated in both methylprednisolone and minocycline treated animals. Conclusion: The results of this study suggest that inflammatory processes may play an important role in the pathophysiology of EBI after SAH. Early treatment with the anti-inflammatory drugs methylprednisolone or minocycline in the acute phase of SAH has the potential to reduce brain damage and exert a neuroprotective effect. 
Introduction
The pathophysiology and treatment of early brain injury (EBI) have been more intensively focussed since drugs that successfully treated delayed cerebral vasospasm (DCV) failed to improve the neurological outcome of patients who suffered aneurysmal subarachnoid hemorrhage (SAH) [1, 2] . The initial presentation, as documented by the Hunt/Hess and WFNS classifications, is still one of the most powerful predictors of long-term outcome. This further points out the importance of EBI [3, 4] .
Furthermore, it cannot be excluded that early pathophysiological changes may significantly influence mechanisms of delayed neurological deterioration occurring later in the course of the disease [5, 6] .
Apart from impaired cerebral perfusion, inflammatory pathways have been reported to contribute to EBI [7, 8] . It is assumed that the accumulation of hemoglobin in the subarachnoid space and contact with collagen fibers trigger an immunological reaction [7] , resulting in the activation of immunomodulators and, finally, diapedesis of leukocytes and macrophages into the brain parenchyma. Degranulation of macrophages, in turn, may result in an amplification of immunological cascades as well as the formation of reactive oxygen species, damaging neurons and glial cells and cerebral blood vessels and thus causing necrotic and apoptotic cell death [9] .
Because of its effect on the glucocorticoid receptor, methylprednisolone (MTP) interferes with the production and effect of inflammatory cytokines, chemokines and cell-adhesion molecules [10] . In addition, glucocorticoids could also target pathomechanisms which inhibit the prostaglandin synthesis early after SAH and cause early vasospasm [11] .
Recently Gomis et al. reported the results of a randomized controlled clinical trial, that patients who were treated with MTP after SAH showed significantly better clinical recovery one year after SAH [12] .
Minocycline (MC) is a tetracycline antibiotic
with the potential to inhibit inflammatory pathways occurring early after SAH. A neuroprotective potential has been observed in neurodegenerative diseases and traumatic brain injury [13, 14] . MC is a lipophilic drug and able to pass the blood brain barrier [15] . It exerts a number of anti-inflammatory mechanisms and may ameliorate the toxic effects of free subarachnoid hemoglobin, which is likely to be a trigger of inflammation after SAH [14, 16] .
It was the aim of this study to investigate the neuroprotective effects of MTP and MC on EBI after experimental SAH.
Material and Methods
For the experiments, 35 male Sprague-Dawley rats (purchased from Charles River, Sulzfeld, Germany) with a body weight between 270g and 370g were used. All experiments were approved by the regional authorities and the district government of Bavaria, Germany.
Anesthesia and monitoring
The rats were anesthetized with 4% Isoflurane 
Experimental groups and intervention

Quantification of subarachnoid blood and histological assessment
Following neurological assessment, the animals were again anesthetized with Isoflurane. Thereafter, an intraperitoneal injection of 1 ml of sodium pentobarbital (Narcoren, Boehringer Ingelheim, Germany) was administered and the animals were transcardially perfused with 4%
paraformaldehyde. The animals' brains were removed and extent of SAH was quantified under the operation microscope using the Sugawara grading scale [20] . A score ranging from 0 to 18 was given based of the amount of blood cloths in six segments of the basal cistern.
Consequently SAH was classified as mild (1 -7), moderate (8 -12) or severe (13 -18) .
After cryo-asservation the perfused brains were cut in 16μm coronary sections using a cryomicrotome (Leica CM3050s, Leica
Mikrosystems Nussloch GmbH, Heidelberg, 
Statistical analysis
Statistical analysis was performed using 
Results
Physiological parameters
Values of arterial blood gases are depicted in Table 1 . There were no significant differences between the groups regarding arterial pH, pO2
and pCO 2 throughout the experiment.
Mean arterial blood pressure, intracranial pressure and cerebral perfusion pressure 
Local cerebral blood flow
In control animals, the ipsilateral LCBF declined 
Extent of hemorrhage, mortality, neurological performance
The average extent of SAH was 10.0 ± 3. 
Histological damage
The However, compared to other studies using this same model, pathophysiological changes were relatively mild in this series of animals [24] .
In particular, ICP increased only moderately, the reason for which may be a relatively low converting enzyme, which play a major role in inflammatory and membrane destabilizing pathways [16, [43] [44] [45] . Furthermore, the direct inhibition of cytokines like tumor necrosis factor α, interleukin 6 or interleukin 1β and the attenuation of caspase dependent and independent apoptosis are further effects of the tetracycline derivate MC [13, 14, 35, 46] . In addition, MC is a potent iron chelator forming iron complexes with the potential to attenuate the inflammatory response by the reduction of its neurotoxic stimulus [14] .
Theoretically, beneficial effects of MTP could also be based on a CBF enhancing capacity via inhibition of prostaglandin synthesis [10] , and leukocyte-endothelium interactions [11] . Similarly, MC may stabilize CBF via inhibition of MMP-9, global microglia activation, and adhesion/diapedesis of leukocytes [45, 47, 48] .
In the present study, an improvement of CBF was not observed in the treatment groups.
In contrast, the treatment groups showed a tendency to lower CBF levels, suggesting that the improvement of neurological performance and attenuation of hippocampal damage are the result of intrinsic anti-inflammatory actions of those two drugs.
EBI after SAH seems to play a major role in the development of bad outcome in this patient population [49, 50] . In a number of studies it has been shown that inflammatory Pathophysiological changes in rodent models may proceed more rapidly than in humans.
Therefore, the endpoint for neurological assessment and histological assessment was deliberately chosen.
Conclusion
In this experimental study, an attenuation of neuronal damage has been observed by therapy with the corticosteroid MTP and the tetracycline MC. Both substances have a number of potentially neuroprotective qualities. Since physiological parameters
were not improved by treatment with either substance, we conclude that the strong antiinflammatory action is most likely to be the key factor for the beneficial effects.
